• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有丝分裂蛋白激酶驱动的有丝分裂和转移机制的串扰。

Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis.

机构信息

Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do, 15588, Korea.

Department of Biological and Health Sciences, Texas A&M University-Kingsville, Kingsville, TX, 78363, USA.

出版信息

Exp Mol Med. 2022 Apr;54(4):414-425. doi: 10.1038/s12276-022-00750-y. Epub 2022 Apr 4.

DOI:10.1038/s12276-022-00750-y
PMID:35379935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9076678/
Abstract

Accumulating evidence indicates that mitotic protein kinases are involved in metastatic migration as well as tumorigenesis. Protein kinases and cytoskeletal proteins play a role in the efficient release of metastatic cells from a tumor mass in the tumor microenvironment, in addition to playing roles in mitosis. Mitotic protein kinases, including Polo-like kinase 1 (PLK1) and Aurora kinases, have been shown to be involved in metastasis in addition to cell proliferation and tumorigenesis, depending on the phosphorylation status and cellular context. Although the genetic programs underlying mitosis and metastasis are different, the same protein kinases and cytoskeletal proteins can participate in both mitosis and cell migration/invasion, resulting in migratory tumors. Cytoskeletal remodeling supports several cellular events, including cell division, movement, and migration. Thus, understanding the contributions of cytoskeletal proteins to the processes of cell division and metastatic motility is crucial for developing efficient therapeutic tools to treat cancer metastases. Here, we identify mitotic kinases that function in cancer metastasis as well as tumorigenesis. Several mitotic kinases, namely, PLK1, Aurora kinases, Rho-associated protein kinase 1, and integrin-linked kinase, are considered in this review, as an understanding of the shared machineries between mitosis and metastasis could be helpful for developing new strategies to treat cancer.

摘要

越来越多的证据表明,有丝分裂蛋白激酶参与转移以及肿瘤发生。蛋白激酶和细胞骨架蛋白在肿瘤微环境中,除了在有丝分裂中发挥作用外,还在肿瘤细胞从肿瘤块中有效释放中发挥作用。有丝分裂蛋白激酶,包括 Polo 样激酶 1(PLK1)和 Aurora 激酶,除了参与细胞增殖和肿瘤发生外,还被证明参与转移,这取决于磷酸化状态和细胞环境。尽管有丝分裂和转移的遗传程序不同,但相同的蛋白激酶和细胞骨架蛋白可以参与有丝分裂和细胞迁移/侵袭,导致迁移性肿瘤。细胞骨架重塑支持包括细胞分裂、运动和迁移在内的多种细胞事件。因此,了解细胞骨架蛋白对细胞分裂和转移运动过程的贡献对于开发治疗癌症转移的有效治疗工具至关重要。在这里,我们确定了在癌症转移和肿瘤发生中起作用的有丝分裂激酶。在本综述中考虑了几种有丝分裂激酶,即 PLK1、Aurora 激酶、Rho 相关蛋白激酶 1 和整合素连接激酶,因为对有丝分裂和转移之间共享机制的理解可能有助于开发治疗癌症的新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/ead93819c803/12276_2022_750_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/8dc650ba09c1/12276_2022_750_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/2d0f721ecd9a/12276_2022_750_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/5711f5695e39/12276_2022_750_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/ead93819c803/12276_2022_750_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/8dc650ba09c1/12276_2022_750_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/2d0f721ecd9a/12276_2022_750_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/5711f5695e39/12276_2022_750_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdf/9076678/ead93819c803/12276_2022_750_Fig4_HTML.jpg

相似文献

1
Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis.有丝分裂蛋白激酶驱动的有丝分裂和转移机制的串扰。
Exp Mol Med. 2022 Apr;54(4):414-425. doi: 10.1038/s12276-022-00750-y. Epub 2022 Apr 4.
2
Cdk1 activity is required for mitotic activation of aurora A during G2/M transition of human cells.在人类细胞的G2/M期转换过程中,Cdk1活性是极光激酶A有丝分裂激活所必需的。
J Biol Chem. 2010 Jul 9;285(28):21849-57. doi: 10.1074/jbc.M110.141010. Epub 2010 May 5.
3
Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.定量磷酸化蛋白质组学鉴定有丝分裂细胞中 Aurora 和 Polo 样激酶活性的底物和功能模块。
Sci Signal. 2011 Jun 28;4(179):rs5. doi: 10.1126/scisignal.2001497.
4
Involvement of polo-like kinase 1 (Plk1) in mitotic arrest by inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase-ribosomal S6 kinase 1 (MEK-ERK-RSK1) cascade.丝氨酸苏氨酸激酶(MAPK)-细胞外信号调节激酶 1(ERK1/2)-核糖体 S6 激酶 1(RSK1)通路的抑制诱导有丝分裂阻滞并涉及 Polo 样激酶 1(Plk1)。
J Biol Chem. 2012 May 4;287(19):15923-34. doi: 10.1074/jbc.M111.312413. Epub 2012 Mar 16.
5
Late mitotic functions of Aurora kinases.极光激酶的有丝分裂后期功能。
Chromosoma. 2017 Feb;126(1):93-103. doi: 10.1007/s00412-016-0594-5. Epub 2016 Apr 22.
6
Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.有丝分裂细胞抽提物中 polo 样激酶-1 上游假定调控因子的纯化和蛋白质组学鉴定。
FEBS Lett. 2010 Oct 22;584(20):4299-305. doi: 10.1016/j.febslet.2010.09.025. Epub 2010 Sep 25.
7
Polo-like kinase-activating kinases: Aurora A, Aurora B and what else?丝氨酸/苏氨酸激酶激活激酶:极光激酶 A、极光激酶 B 还有其他什么激酶?
Cell Cycle. 2012 Apr 15;11(8):1490-5. doi: 10.4161/cc.19724.
8
Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.Polo样激酶1和极光激酶的共同抑制促进有丝分裂灾难。
Oncotarget. 2015 Apr 20;6(11):9327-40. doi: 10.18632/oncotarget.3313.
9
Axin localizes to mitotic spindles and centrosomes in mitotic cells.Axin定位于有丝分裂细胞的有丝分裂纺锤体和中心体。
Exp Cell Res. 2009 Apr 1;315(6):943-54. doi: 10.1016/j.yexcr.2009.01.013. Epub 2009 Jan 30.
10
Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.有丝分裂 DNA 损伤反应:Polo 样激酶-1 通过 ATM-Chk1 途径去磷酸化。
Cell Cycle. 2010 Jun 15;9(12):2389-98. doi: 10.4161/cc.9.12.11904.

引用本文的文献

1
PLK1 in cancer therapy: a comprehensive review of immunomodulatory mechanisms and therapeutic opportunities.PLK1在癌症治疗中的作用:免疫调节机制与治疗机会的全面综述
Front Immunol. 2025 Jun 19;16:1602752. doi: 10.3389/fimmu.2025.1602752. eCollection 2025.
2
Aurora kinases signaling in cancer: from molecular perception to targeted therapies.极光激酶在癌症中的信号传导:从分子认知到靶向治疗
Mol Cancer. 2025 Jun 18;24(1):180. doi: 10.1186/s12943-025-02353-3.
3
Design, synthesis, and biological evaluation of novel -(1-indazol-6-yl)benzenesulfonamide derivatives as potent PLK4 inhibitors.

本文引用的文献

1
Overexpression of ROCK1 promotes cancer cell proliferation and is associated with poor prognosis in human urothelial bladder cancer.ROCK1的过表达促进癌细胞增殖,并与人类膀胱尿路上皮癌的不良预后相关。
Mamm Genome. 2021 Dec;32(6):466-475. doi: 10.1007/s00335-021-09896-y. Epub 2021 Jul 28.
2
PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma.PLK1/波形蛋白信号通过将 Smad2/3 募集到转移性肺腺癌的 PD-L1 启动子上来促进免疫逃逸。
Cell Death Differ. 2021 Sep;28(9):2745-2764. doi: 10.1038/s41418-021-00781-4. Epub 2021 May 7.
3
PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis.
新型-(1-吲唑-6-基)苯磺酰胺衍生物作为有效的PLK4抑制剂的设计、合成及生物学评价
RSC Med Chem. 2025 May 13. doi: 10.1039/d5md00251f.
4
CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer.CK2α介导的GRP94磷酸化促进三阴性乳腺癌的转移级联反应。
Cell Death Discov. 2024 Apr 22;10(1):185. doi: 10.1038/s41420-024-01956-x.
5
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.抑制 AURKA/YAP1 轴是克服结直肠癌细胞干细胞中西妥昔单抗耐药的一种有前途的治疗选择。
Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11.
6
Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.托扎司替布通过减少黑色素瘤中的调节性 T 细胞来激活抗肿瘤免疫。
Neoplasia. 2024 Feb;48:100966. doi: 10.1016/j.neo.2024.100966. Epub 2024 Jan 18.
7
Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1.PLK1 磷酸化的侵袭性 FoxM1 诱导肿瘤相关巨噬细胞极化,促进免疫逃逸和转移,被 IFITM1 放大。
J Exp Clin Cancer Res. 2023 Nov 16;42(1):302. doi: 10.1186/s13046-023-02872-1.
8
PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC.PLK1 介导的 β-连环蛋白磷酸化增强了其稳定性,并使其转录活性增强,从而促进转移性非小细胞肺癌细胞外基质重塑。
Theranostics. 2023 Feb 5;13(3):1198-1216. doi: 10.7150/thno.79318. eCollection 2023.
9
Inhibitors of One or More Cellular Aurora Kinases Impair the Replication of Herpes Simplex Virus 1 and Other DNA and RNA Viruses with Diverse Genomes and Life Cycles.一种或多种细胞 Aurora 激酶抑制剂可破坏单纯疱疹病毒 1 及其他具有不同基因组和生命周期的 DNA 和 RNA 病毒的复制。
Microbiol Spectr. 2023 Feb 14;11(1):e0194322. doi: 10.1128/spectrum.01943-22. Epub 2022 Dec 20.
10
Computational Biology Dynamics of Mps1 Kinase Molecular Interactions with Isoflavones Reveals a Chemical Scaffold with Potential to Develop New Therapeutics for the Treatment of Cancer.计算生物学:Mps1 激酶与异黄酮分子相互作用的动力学研究揭示了一种具有开发新型癌症治疗药物潜力的化学支架。
Int J Mol Sci. 2022 Nov 17;23(22):14228. doi: 10.3390/ijms232214228.
PLK1诱导染色体不稳定并绕过细胞周期检查点以驱动肿瘤发生。
Cancer Res. 2021 Mar 1;81(5):1293-1307. doi: 10.1158/0008-5472.CAN-20-1377. Epub 2020 Dec 29.
4
Centrosomes in mitotic spindle assembly and orientation.中心体在有丝分裂纺锤体组装和定向中的作用。
Curr Opin Struct Biol. 2021 Feb;66:193-198. doi: 10.1016/j.sbi.2020.11.003. Epub 2020 Dec 6.
5
Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma.靶向 ROCK1/2 可阻断细胞分裂并诱导肝癌中的有丝分裂灾难。
Biochem Pharmacol. 2021 Feb;184:114353. doi: 10.1016/j.bcp.2020.114353. Epub 2020 Dec 2.
6
MicroRNA-based regulation of Aurora A kinase in breast cancer.基于微小RNA对乳腺癌中极光激酶A的调控
Oncotarget. 2020 Nov 17;11(46):4306-4324. doi: 10.18632/oncotarget.27811.
7
Genomic control of metastasis.基因组控制转移。
Br J Cancer. 2021 Jan;124(1):3-12. doi: 10.1038/s41416-020-01127-6. Epub 2020 Nov 4.
8
The focal adhesion protein Integrin-Linked Kinase (ILK) as an important player in breast cancer pathogenesis.整合素连接激酶(ILK)作为乳腺癌发病机制中的一个重要参与者,是一种焦点黏附蛋白。
Cell Adh Migr. 2020 Dec;14(1):204-213. doi: 10.1080/19336918.2020.1829263.
9
Promotes the Metastasis of Gastric Cancer, Possibly by Inducing EMT.可能通过诱导上皮-间质转化促进胃癌转移。
Cancer Manag Res. 2020 Aug 5;12:6947-6958. doi: 10.2147/CMAR.S254250. eCollection 2020.
10
Aurora-B Promotes Osteosarcoma Cell Growth and Metastasis Through Activation of the NPM1/ERK/NF-κβ/MMPs Axis.极光激酶B通过激活NPM1/ERK/NF-κβ/基质金属蛋白酶轴促进骨肉瘤细胞生长和转移。
Cancer Manag Res. 2020 Jun 23;12:4817-4827. doi: 10.2147/CMAR.S252847. eCollection 2020.